• Protocols

• A072201

  OPEN TO ACCRUAL

  Randomized Ph2 Trial of Anti-lag-3 & Anti-pd-1 Blockade vs Soc in Patients W/Recurrent Glioblastoma
  
  

• NCI10559

  OPEN TO ACCRUAL

  PII Erdafitinib for Recurrent or Progressive IDH-WT Glioma w/FGFR-TACC Gene Fusion